Endocrine, Metabolic & Immune Disorders - Drug Targets
Title:AME Board of Directors 2021-2022
Volume: 21 Issue: 6
Author(s):
Affiliation:
Export Options
About this article
Cite this article as:
, AME Board of Directors 2021-2022, Endocrine, Metabolic & Immune Disorders - Drug Targets 2021; 21 (6) . https://dx.doi.org/10.2174/187153032106210614150550
DOI https://dx.doi.org/10.2174/187153032106210614150550 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
2
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements